UNSPSC 51441704: Barium sulfate/methylcellulose

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DX101. This VA Drug Class (DX101) classifies this compound as belonging to the group NON-IONIC CONTRAST MEDIA.

UNSPSC 51441704 Barium sulfate/methylcellulose is a Commodity code that in practice encompasses a narrower range of radiologic and diagnostic imaging consumables and services than its name suggests. Recent state and local opportunities under this code include radiologic equipment procurement and installation, X-ray system warranties and maintenance services, and diagnostic imaging equipment components. Issuing bodies are primarily county governments and county-affiliated agencies — Maricopa County, Escambia County Correction, Broward County Aviation Department, and Pasco County have all posted opportunities in the past four months. The code also captures as-needed supply contracts for chemical consumables used in industrial or water-treatment contexts, though the recent activity under the code's nominal scope focuses on medical imaging equipment and related services rather than the chemical products the code name implies.

Solicitation activity is concentrated in Florida and Arizona. Maricopa County issued IFB 362910 on October 1, 2026, seeking radiologic equipment and installation services at three colleges, with proposals due October 22, 2026. Escambia County Correction posted sole-source IFB SSCORALM2526005 on August 12, 2026, for an extended warranty on X-ray machines, closing August 19, 2026. Broward County Aviation Department issued RFI BLD2132311F1 on June 25, 2026, inviting responses on maintenance services for Rapiscan X-ray inspection systems and challenging the proposed sole-source designation, with responses due July 28, 2026. Pasco County, Florida posted RFQ FP261004 on June 3, 2026, seeking as-needed supply of large copper sulfate crystals and liquid copper sulfate, due June 26, 2026. The code shows moderate activity, though the divergence between the chemical focus of the code name and the medical-imaging emphasis of recent opportunities suggests potential miscoding by issuing bodies.